Chief Executive Officer

Closing date: 04 October 2026 at 23:30
  • Circa £90,000 full-time (35 hours).
  • Permanent contract.
  • Hybrid role.

Lead the next chapter for liver health in the UK.

This is a unique opportunity to lead a respected and financially stable health charity at a pivotal moment of transformation.
Following a successful merger, the organisation has proudly just completed a full rebrand to Liver UK, bringing together services, information and advocacy across all ages. With a clear, trustee-approved strategy for 2026–2032 already in place, the next Chief Executive will focus on delivery, growth and national influence.

As Chief Executive, you will lead delivery of an established strategy, ensuring the organisation continues to grow its reach, impact and income.  You will work closely with an engaged and supportive Board of Trustees to maintain high standards of governance, regulatory compliance and risk management, while strengthening the charity’s voice in national policy and public affairs.
This is a role that balances external influence with internal leadership, ensuring both impact and organisational resilience.

For full details of the role and to apply, visit Charity Jobs.

A competitive salary will be offered, reflecting the experience, skills and leadership qualities of the successful candidate.

 

We offer a range of benefits for our employees:

  • 25 days elective annual leave, plus bank holidays.
  • Life assurance 4x your salary starting from date of employment.
  • 5% employer pension contribution, rising to 7.5% at 15 months and 10% at 27 months service (optional on contribution increase).
  • Full pay for paternity leave (2 weeks) and two weeks of maternity leave on full pay (in addition to statutory 6 weeks at 90%).
  • BUPA Wellbeing Health Expenses plan; including dental, prescriptions and optical cover
  • Cycle to Work Scheme
  • Potential for flexible working

And many more…

Latest news

Our Budget Case to the Treasury: Investing in Prevention

Our Budget Case to the Treasury: Investing in Prevention

The Autumn Budget on 28th October is a chance to prevent thousands of families from experiencing the devastating impact of liver disease. Because 90% of liver disease is preventable, government action on alcohol harm and obesity could ...
Liver UK helps shape new European recommendations on liver cancer surveillance

Liver UK helps shape new European recommendations on liver cancer surveillance

A major new paper published in The Lancet Regional Health – Europe has highlighted the challenges of detecting liver cancer earlier across Europe and sets out practical lessons from countries around the world to improve surveillance ...
The LIVERAGE research studies

The LIVERAGE research studies

The LIVERAGE and LIVERAGE Cirrhosis studies are large clinical research studies for adults living with MASLD, a type of fatty liver disease. These studies focus on people with MASH, a more advanced form of MASLD.  The studies include ...
No results found.
[page-content]
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.